Shared Care Protocols
Shared Care Protocols outline prescribing and monitoring responsibilities for the specialist and the GP.
Shared Care Protocols (SCPs) are used to allow prescribing to be taken on by a patient's GP once the patient is stable.
If you are a clinician and want to develop a shared care protocol please click here to contact us.
Below is a list of approved Shared Care Protocols:
ADHD adult
- ADHD adult - dexamfetamine shared care protocol (259 kb) Review date: January 2025
- ADHD adult - lisdexamfetamine shared care protocol (277 kb) Review date: January 2025
- ADHD adult - methylphenidate shared care protocol (285 kb) Review date: January 2025
- ADHD adult- atomoxetine shared care protocol (228 kb) Review date: January 2025
ADHD children and young people
- ADHD children and young people - shared care protocol (636 kb) Review date: December 2022
- ADHD children and young people - atomoxetine information sheet (244 kb) Review date: December 2022
- ADHD children and young people - dexamfetamine information sheet (188 kb) Review date: December 2022
- ADHD children and young people - lisdexamfetamine information sheet (194 kb) Review date: December 2022
- ADHD children and young people - methylphenidate information sheet (231 kb) Review date: December 2022
Cardiovascular conditions
- Amiodarone shared care protocol (414 kb) Review date: January 2025
- Amiodarone Primary Care Supporting Document (91 kb) Review date: Jan 2024
- Dronedarone- overarching SCP (51 kb) Review date: Dec 2022
- Dronedarone- information sheet (94 kb) Review date: Dec 2022
Children and adolescents
- Growth hormone - overarching SCP (216 kb) Review date: Feb 2025
- Growth hormone - information sheet (336 kb) Review date: Feb 2025
- Testosterone for Hypogonadism and Constitutional Delay in Growth and Puberty in children and adolescents; Overarching Shared Care Protocol (278 kb) Review date: Jan 2026
- Testosterone in male children and adolescents; Information Sheet (234 kb) Review date: Jan 2026
Dermatological conditions
- Dermatological conditions- overarching scp (242 kb) Review date: November 2023
- Dermatological conditions- azathioprine information sheet (324 kb) Review date: November 2023
- Dermatological conditions- hydroxychloroquine information sheet (106 kb) Review date: May 2023
- Dermatological conditions- methotrexate information sheet (181 kb) Review date: November 2023
Inflammatory Bowel Disease
- Inflammatory bowel disease - overarching SCP (246 kb) Review date: Nov 2023
- Inflammatory bowel disease - Azathioprine for children >12 years (264 kb) Review date: June 2022
- Inflammatory bowel disease - azathioprine information sheet (370 kb) Review date: Nov 2023
- Inflammatory bowel disease - mercaptopurine information sheet (375 kb) Review date: Nov 2023
- Inflammatory bowel disease - Methotrexate information sheet (326 kb) Review date: Nov 2023
Neurological conditions
- Neuroinflammatory conditions - azathioprine overarching SCP (701 kb) Review date: November 2023
- Neuroinflammatory conditions - azathioprine information sheet (638 kb) Review date: November 2023
- Parkinson's disease - overarching SCP (211 kb) Review date: April 2023
- Parkinson's disease - apomorphine information sheet (161 kb) Review date: April 2023
- Riluzole for Motor Neurone Disease- Overarching SCP (212 kb) Review date: April 2024
- Riluzole for Motor Neurone Disease- Information Sheet (189 kb) Review date: April 2024
Renal conditions
- Phosphate Binders - overarching SCP (267 kb) Review date: March 2026
- Phosphate binders - information sheet (182 kb) Review date: March 2026
Rheumatological conditions
- Rheumatological conditions - overarching SCP (223 kb) Review date: July 2023
- Rheumatological conditions - DMARDs Summary of Monitoring (528 kb) Review date: July 2023
- Rheumatological conditions - azathioprine information sheet (197 kb) Review date: July 2023
- Rheumatological conditions - ciclosporin information sheet (260 kb) Review date: July 2023
- Rheumatological conditions - injectable gold information sheet (352 kb) Review date: July 2023
- Rheumatological conditions - hydroxychloroquine information sheet (300 kb) Review date: July 2023
- Rheumatological conditions - leflunomide information sheet (207 kb) Review date: July 2023
- Rheumatological conditions - methotrexate information sheet (212 kb) Review date: July 2023
- Rheumatological conditions - penicillamine information sheet (340 kb) Review date: July 2023
- Rheumatological conditions - sulphasalazine information sheet (194 kb) Review date: July 2023
Transgender
- Transgender Collaborative Care Protocol (167 kb) Review date: July 2025
- Transgender - feminising hormones information sheet (336 kb) Review date: July 2025
- Transgender - masculinising hormones information sheet (323 kb) Review date: July 2025
A-Z of other Shared Care Protocols
- Auto-immune Hepatitis- overarching SCP (663 kb) Review date: Sep 2023
- Auto-immune Hepatitis- azathioprine information sheet (297 kb) Review date: Sep 2023
- Valproate medicines for patients of child-bearing potential - shared care protocol (384 kb) Review date: January 2025